©worldofvector [[www.123rf.com 123rf.com]]</span>A programme that offered financial incentives to both patients and their physicians to control low-density lipoproteins (LDL) cholesterol could be a cost-effective intervention for patients at high risk of cardiovascular disease (CVD), according to new research led by Harvard TH Chan School of Public Health.
Read more... | Send to a friend
↧
Increasing cholesterol medication adherence with financial incentives may be cost-effective
↧